MDRX — Veradigm Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid Cap

Annual income statement for Veradigm, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2017 December 31st	R2018 December 31st	R2019 December 31st	2020 December 31st	2021 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,498	1,618	1,633	1,503	1,503
Cost of Revenue
Gross Profit	633	621	610	566	620
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	1,651	1,629	1,733	1,635	1,417
Operating Profit	-153	-11.6	-100	-132	85.6
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-190	-62.2	-282	-149	162
Provision for Income Taxes
Net Income After Taxes	-169	-43.2	-241	-133	134
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-196	364	-182	700	134
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-196	364	-182	700	134
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.333	-0.534	-1.3	-0.52	0.987